South Plainfield, NJ, United States of America

Chan H Kuo


Average Co-Inventor Count = 6.0

ph-index = 2

Forward Citations = 31(Granted Patents)


Company Filing History:


Years Active: 1991-1992

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Innovations of Chan H Kuo

Introduction

Chan H Kuo is a notable inventor based in South Plainfield, NJ (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of novel compounds. With a total of three patents to his name, Kuo's work has implications for medical advancements.

Latest Patents

Among his latest patents are the inventions related to 2,5-diaryl tetrahydrofurans and their analogs as PAF antagonists. The first patent describes a specifically substituted tetrahydrofuran of the formula (I), wherein R⁴ is an alkylthio, alkylsulfinyl, or alkylsulfonyl containing group. At least one of the substituents at positions 3, 4, or 5 contains a heterocyclic, heteroaryl, or substituted phenylthio moiety. The second patent also focuses on 2,5-diaryl tetrahydrofurans and analogs as PAF antagonists, detailing a tetrahydrofuran where Ar is a pyridyl, a dimethoxy-pyridyl, or dimethoxy-pyrazyl group, with similar substituent characteristics.

Career Highlights

Chan H Kuo is currently associated with Merck & Company, Inc., a leading global healthcare company. His work at Merck has allowed him to explore innovative solutions in drug development and contribute to the advancement of therapeutic options.

Collaborations

Kuo has collaborated with notable colleagues, including Tesfaye Biftu and Nirindar N Girotra, who have also contributed to the field of pharmaceutical research. Their teamwork has fostered an environment of innovation and discovery.

Conclusion

Chan H Kuo's contributions to the field of pharmaceuticals through his patents and collaborations highlight his role as an influential inventor. His work continues to pave the way for advancements in medical science.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…